|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 213/60 | |
| C07D 401/04 | |||
| C07D 401/12 | |||
| C07D 405/12 | |||
| C07D 413/12 | |||
| C07D 417/12 | |||
| C07D 471/04 | |||
| C07D 487/04 | |||
| A61K 31/4353 | |||
| A61K 31/4427 | |||
| A61K 31/506 | |||
| A61K 31/519 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3124472 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16167542.6 |
| Europos patento paraiškos padavimo data | 2011-12-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-02-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-07-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (72) |
ZHOU, Changyou, US
WANG, Shaohui, CN
ZHANG, Guoliang, CN
|
| (73) |
BeiGene, Ltd.,
Mourant Ozannes Corporate Services (Cayman) Limited 94 Solaris Avenue, Camana Bay, Grand Cayman KY1-1108,
KY
|
| (54) | FUSED TRICYCLIC COMPOUNDS AS RAF KINASE INHIBITORS |
| FUSED TRICYCLIC COMPOUNDS AS RAF KINASE INHIBITORS |